LGALS3 and hydrops fetalis: Initial clinical studies showed that while galectin-3 lacked utility for HF diagnosis, galectin-3 was an independent prognostic factor for all-cause mortality and HF hospitalization, suggesting it had use as a prognostic biomarker [141,142,143].